kuru

Kuru

Introduction

Kuru is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Kuru is a rare, invariably fatal [prion-disease](/diseases/prion-disease) that was endemic among the Fore people of the Eastern Highlands Province of Papua New Guinea. First described in the early 1950s, kuru is transmitted through ritualistic funerary cannibalism—the practice of consuming the tissues, particularly the brain, of deceased family members. The disease is classified as a transmissible spongiform encephalopathy (TSE), caused by the accumulation of misfolded [prnp-protein](/proteins/prnp-protein) in the brain, leading to progressive cerebellar ataxia, tremor, and death within 6–24 months of symptom onset [@aiman2024] [Link](https://pmc.ncbi.nlm.nih.gov/articles/PMC4235695/). [@liberski2014]

Kuru holds a unique place in the history of neuroscience and infectious disease. Its investigation by D. Carleton Gajdusek and colleagues, which earned Gajdusek the 1976 Nobel Prize in Physiology or Medicine, established the concept of transmissible neurodegenerative diseases and laid the groundwork for Stanley Prusiner's later discovery of prions. Kuru is the prototype human Prion Disease and remains central to our understanding of prion biology, the genetics of prion susceptibility, and the evolutionary response to epidemic prion exposure [@liberski2012]. [@liberski2012]

--- [@whitfield2017]

History and Discovery

Early Reports

...

Kuru

Introduction

Kuru is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Kuru is a rare, invariably fatal [prion-disease](/diseases/prion-disease) that was endemic among the Fore people of the Eastern Highlands Province of Papua New Guinea. First described in the early 1950s, kuru is transmitted through ritualistic funerary cannibalism—the practice of consuming the tissues, particularly the brain, of deceased family members. The disease is classified as a transmissible spongiform encephalopathy (TSE), caused by the accumulation of misfolded [prnp-protein](/proteins/prnp-protein) in the brain, leading to progressive cerebellar ataxia, tremor, and death within 6–24 months of symptom onset [@aiman2024] [Link](https://pmc.ncbi.nlm.nih.gov/articles/PMC4235695/). [@liberski2014]

Kuru holds a unique place in the history of neuroscience and infectious disease. Its investigation by D. Carleton Gajdusek and colleagues, which earned Gajdusek the 1976 Nobel Prize in Physiology or Medicine, established the concept of transmissible neurodegenerative diseases and laid the groundwork for Stanley Prusiner's later discovery of prions. Kuru is the prototype human Prion Disease and remains central to our understanding of prion biology, the genetics of prion susceptibility, and the evolutionary response to epidemic prion exposure [@liberski2012]. [@liberski2012]

--- [@whitfield2017]

History and Discovery

Early Reports

Kuru was first documented by Australian colonial officers patrolling the Eastern Highlands of Papua New Guinea. In 1951, Arthur Carey was the first to use the term "kuru" in an official report, describing a mysterious illness affecting the Fore linguistic group. The word "kuru" derives from the Fore language and means "to tremble" or "to shiver," reflecting the prominent tremor observed in affected individuals [@aiman2024]. [@mclean2009]

Gajdusek's Investigation

In 1957, D. Carleton Gajdusek, an American virologist and pediatrician, and Vincent Zigas, an Australian physician, published the first scientific descriptions of kuru. Gajdusek traveled to the region and spent years studying the disease, initially suspecting a genetic cause due to its high prevalence within specific kinship groups. However, the striking demographic distribution—with women and children affected 8–9 times more frequently than men—eventually pointed toward an environmental rather than purely genetic etiology [@liberski2014]. [@hainfellner1997]

Establishing Transmissibility

In 1966, Gajdusek and colleagues demonstrated that kuru could be transmitted to chimpanzees by intracerebral inoculation of brain tissue from deceased kuru patients, proving that kuru was an infectious disease with incubation periods of 1–4 years in primates. This revolutionary finding established the concept of "slow virus infections"—a category later redefined as prion diseases after Prusiner's identification of the proteinaceous infectious agent in the 1980s [@liberski2012]. [@mead2009]

Link to Cannibalism

The connection between kuru and funerary cannibalism was gradually established through epidemiological and anthropological studies. Among the Fore people, ritualistic endocannibalism was practiced as part of mourning rites: deceased family members were cooked and consumed, with women and children typically eating the brain and internal organs, while men consumed muscle tissue or abstained entirely (believing that consuming human flesh would weaken them in warfare). This practice concentrated infectious prion particles in the most susceptible demographic groups [@aiman2024] [Link](https://royalsocietypublishing.org/rsos/article/4/1/160789/36747/Cultural-factors-that-affected-the-spatial-and). [@asante2015]

--- [@callaway2015]

Epidemiology

Peak of the Epidemic

At its height in the late 1950s, kuru killed approximately 1–2% of the Fore population annually, with mortality rates reaching 35 per 1,000 in the most affected villages. In some communities, kuru was the leading cause of death, particularly among women of reproductive age, creating severe demographic imbalances with male-to-female ratios exceeding 3:1 in some areas [@liberski2014]. [@gajdusek1957]

Decline of the Disease

The Australian colonial administration banned cannibalism in the late 1950s, and the practice was largely eliminated by 1960. The number of new kuru cases declined steadily thereafter: [@prusiner1982]

• 1957–1960: ~200 deaths per year among the Fore population (~11,000 people)
• 1970s: Cases increasingly confined to older individuals with long incubation periods
• 1990s–2000s: Sporadic cases with incubation periods estimated at 34–56 years
• 2005: Last recorded case of kuru
• 2009: Last documented death from kuru [@aiman2024]

Incubation Period

Kuru has one of the longest known incubation periods for any infectious disease: [@collinge2006]

• Minimum: Approximately 5 years (in children heavily exposed through cannibalism)
• Average: 10–13 years
• Maximum: 50+ years (cases documented in the 2000s in individuals who participated in cannibalism before the ban in the late 1950s)

The extraordinarily long incubation period is influenced by the [PRNP codon 129 polymorphism]: individuals homozygous for methionine (MM) tend to have shorter incubation periods, while heterozygotes (MV) and valine homozygotes (VV) have longer incubation periods [@liberski2012].

Clinical Features

Disease Stages

Kuru progresses through three clinically defined stages over approximately 3–9 months, though some cases lasted up to 2 years:

Ambulatory Stage (1–3 months)

• Unsteady gait and stance (cerebellar ataxia)
• Mild tremor, initially postural
• Dysarthria (slurred speech)
• Astasia (inability to stand without support)
• Convergent strabismus (eye crossing)
• Emotional lability with inappropriate laughter (the "laughing death")

Sedentary Stage (2–3 months)

• Progressive inability to walk without support
• Severe tremor at rest and with intention
• Ataxia affecting trunk and limbs
• Choreiform and athetoid movements
• Muscle jerks and fasciculations
• Emotional instability with sudden outbursts of laughter or sadness

Terminal Stage (1–3 months)

• Complete inability to sit or stand
• Urinary and fecal incontinence
• Dysphagia (difficulty swallowing)
• Profound muscle wasting
• Decubitus ulcers
• Death from pneumonia, infection, or inanition

Unlike [cjd](/diseases/cjd), dementia was notably absent or minimal in kuru until the terminal stages, and the predominant clinical picture was cerebellar in nature [@aiman2024] [Link](https://pmc.ncbi.nlm.nih.gov/articles/PMC2735511/).

Neuropathology

Macroscopic Features

• Generalized cerebral and cerebellar atrophy
• Particularly prominent cerebellar cortical atrophy
• Normal-appearing deep gray matter structures

Microscopic Hallmarks

The neuropathological triad of kuru consists of:

Spongiform change: Widespread vacuolation of the neuropil, affecting all cortical areas except the occipital [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), and insular gyri. Prominent changes in the [putamen](/brain-regions/putamen), caudate, and cerebellar [cortex](/brain-regions/cortex) [@mclean2009].

Neuronal loss: Severe depletion of [neurons](/entities/neurons), especially Purkinje cells in the [cerebellum](/brain-regions/cerebellum), and [neurons](/entities/neurons) in the [striatum](/brain-regions/striatum) and [thalamus](/brain-regions/thalamus).

Astrocytic gliosis: Reactive [astrocytes](/cell-types/astrocytes) proliferation throughout affected brain regions.

Kuru Plaques

The pathognomonic feature of kuru is the presence of PrP amyloid plaques (kuru plaques):

• Unicentric, spherical deposits of misfolded PrP^Sc^
• Predominantly located in the granular layer of the [cerebellum](/brain-regions/cerebellum)
• Often surrounded by a halo of spongiform change
• Frequently associated with microglial but are larger and more "florid" in vCJD [@mclean2009] [Link))](https://https://pubmed.ncbi.nlm.nih.gov/9034563/).

Genetics and Prion Susceptibility

PRNP Codon 129 Polymorphism

The methionine/valine (M/V) polymorphism at codon 129 of the [prnp](/genes/prnp) is the major genetic determinant of susceptibility to kuru and other prion diseases:

| Genotype | Susceptibility | Incubation Period | Notes |
|----------|---------------|-------------------|-------|
| 129MM | Highest | Shortest (5–10 years) | Most affected during early epidemic |
| 129MV | Moderate | Intermediate (10–30 years) | Heterozygous advantage |
| 129VV | Lower | Longest (20–50+ years) | Cases appeared late in epidemic |

Heterozygosity at codon 129 (MV) confers partial protection—a form of balancing selection that has been driven by historical Prion Disease exposure in human populations [@liberski2012] [Link))](https://https://www.nejm.org/doi/full/10.1056/NEJMoa0809716).

G127V: The Kuru-Resistance Polymorphism

One of the most remarkable discoveries from kuru research is the identification of the G127V polymorphism in PRNP:

• Found exclusively in the Fore population and their neighbors—it does not occur in any other human population.
• Present only among kuru survivors and their descendants, not among kuru victims.
• In the heterozygous state (G127V), it confers strong resistance to kuru.
• Transgenic mice expressing both variant (127V) and wild-type (127G) human PrP are completely resistant to both kuru and classical [creutzfeldt-jakob](/diseases/creutzfeldt-jakob) prions.
• Homozygous 127VV mice show dominant-negative inhibition of prion propagation.
• This represents a striking example of recent positive selection in humans, driven by the kuru epidemic over approximately 200 years of prion exposure [@mead2009] [Link))](https://https://pmc.ncbi.nlm.nih.gov/articles/PMC4486072/).

Evolutionary Implications

The kuru epidemic left a lasting genetic imprint on the Fore population:

• Strong selection for PRNP codon 129 heterozygosity
• Emergence and rapid spread of the G127V protective variant
• These findings suggest that Prion Disease exposure may have been more widespread in human evolutionary history than previously recognized, potentially linked to endocannibalism practices in prehistoric populations [@liberski2014] [Link))](https://https://www.scientificamerican.com/article/genetic-mutation-found-to-block-prion-disease-in-tribe-that-used-to-practice-ritual-cannibalism/).

Relationship to Other Prion Diseases

Kuru belongs to the family of [prion-diseases](/diseases/prion-diseases) (transmissible spongiform encephalopathies), sharing core mechanisms of PrP misfolding and propagation:

| Disease | Species | Route | Key Features |
|---------|---------|-------|--------------|
| Kuru | Human | Dietary (cannibalism) | Cerebellar ataxia, kuru plaques |
| [creutzfeldt-jakob](/diseases/creutzfeldt-jakob) | Human | Sporadic/genetic/iatrogenic | Rapidly progressive dementia |
| vCJD | Human | Dietary (BSE) | Young onset, florid plaques |
| FFI | Human | Genetic (D178N-129M) | Fatal insomnia, thalamic degeneration |
| [gss](/diseases/gss) | Human | Genetic (P102L, others) | Cerebellar ataxia, PrP plaques |
| Scrapie | Sheep/goats | Natural transmission | The original TSE |
| [bse](/entities/bse) | Cattle | Feed contamination | "Mad cow disease" |

Kuru and vCJD share neuropathological similarities (amyloid plaques, spongiform change, cerebellar involvement), both being acquired through dietary exposure to prion-contaminated tissue [@mclean2009].

Scientific Legacy

Kuru's investigation yielded foundational contributions to science and medicine:

Established Prion Disease transmissibility: Gajdusek's chimpanzee experiments proved that neurodegenerative diseases could be infectious—a concept that was revolutionary at the time.

Led to prion discovery: Work on kuru and scrapie directly contributed to Prusiner's identification of the prion protein.

Demonstrated extremely long incubation periods: Kuru showed that infectious agents could have incubation periods spanning decades—relevant to understanding [variant-cjd](/diseases/variant-cjd) and other slow infections.

Revealed natural selection by infectious disease: The G127V polymorphism is one of the clearest examples of recent positive selection in humans driven by an infectious pathogen.

Informed Prion Disease surveillance: Lessons from kuru epidemiology shaped public health responses to BSE/vCJD and continue to influence Prion Disease surveillance programs [@liberski2014] [Link))](https://https://pmc.ncbi.nlm.nih.gov/articles/PMC5120877/).

• [All Diseases
• [--](/proteins/n--cadherin-protein)

Background

The study of Kuru has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

Recent Research (2024-2026)

Recent advances in Kuru have focused on understanding disease mechanisms, identifying biomarkers, and developing novel therapeutic approaches. Key developments include:

• Genetic studies: Identification of new genetic risk factors and mechanistic insights
• Biomarker research: Development of diagnostic and prognostic biomarkers
• Therapeutic approaches: Investigation of novel treatment strategies
• Clinical trials: Ongoing Phase I-III trials for new therapies

References

Unknown, Aiman W, Gasalbardes S, Lu Y. (2024). Kuru. StatPearls. Treasure Island, FL: StatPearls Publishing. [Link) (2024)

Unknown, Liberski PP, Sikorska B, Guiroy D, Bhatt N. (2014). Kuru: A journey back in time from Papua New Guinea to the Neanderthals' extinction. Pathogens, 3(3), 700–713. [Link) (2014)

Liberski PP, et al., (2012). Kuru: Genes, cannibals and neuropathology. Journal of Neuropathology and Experimental Neurology, 71(2), 92–103. [Link) (2012)

Whitfield JT, et al., (2017). Cultural factors that affected the spatial and temporal epidemiology of kuru. Royal Society Open Science, 4(1), 160789. [Link) (2017)

McLean CA, et al., (2009). The neuropathology of kuru and variant Creutzfeldt-Jakob Disease. Philosophical Transactions of the Royal Society B, 363(1510), 3685–3687. [Link) (2009)

[Hainfellner JA, et al., (1997). Pathology and immunocytochemistry of a kuru brain. Brain Pathology, 7(1), 547–553. [Link) (1997)](https://pubmed.ncbi.nlm.nih.gov/9034563/)

Mead S, et al., (2009). A novel protective prion protein variant that colocalizes with kuru exposure. New England Journal of Medicine, 361, 2056–2065. [Link) (2009)

Asante EA, et al., (2015). A naturally occurring variant of the human prion protein completely prevents Prion Disease. Nature, 522, 478–481. [Link) (2015)

Unknown, Callaway E. (2015). Genetic mutation found to block Prion Disease in tribe that used to practice ritual cannibalism. Scientific American. [Link) (2015)

Gajdusek DC, Zigas V, (1957) (1957)

Prusiner SB, (1982) (1982)

Collinge J, et al, (2006) (2006)